Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Retinol may affect immune responses in people with frequent skin boils.

MicroRNAs can reprogram cells into stem cells faster and more efficiently than traditional methods.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

ACTH promotes hair growth in mink, but α-MSH does not.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Psychotropic drugs can interact with natural products, affecting their effectiveness and safety.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Upadacitinib improved multiple immune-related conditions in one patient.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

Topical immunotherapy is the best treatment for severe alopecia areata.

γδ T cells adapt uniquely to different tissues in mice.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Prevelex, a polyampholyte, can create a cell-repellent coating on microdevices, which can be useful in biomedical applications like hair follicle regeneration.

Targeting specific T cells may help treat alopecia areata.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Bioinspired polymers are promising for advanced medical treatments and tissue repair.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.